Rapid next-generation sequencing aids in diagnosis of transient abnormal myelopoiesis in a phenotypically normal newborn.

Aziz-Bose, Rahela; Wachter, Franziska; Chiarle, Roberto; Lindeman, Neal I; Kim, Annette S; Degar, Barbara A; Davies, Kimberly; Pikman, Yana

Aziz-Bose, Rahela; Wachter, Franziska; Chiarle, Roberto; Lindeman, Neal I; Kim, Annette S; Degar, Barbara A; Davies, Kimberly; Pikman, Yana.

Afiliação

Aziz-Bose R; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA.
Wachter F; Harvard Medical School, Boston, MA.
Chiarle R; Division of Hematology/Oncology, Boston Children's Hospital, Boston, MA.
Lindeman NI; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA.
Kim AS; Harvard Medical School, Boston, MA.
Degar BA; Division of Hematology/Oncology, Boston Children's Hospital, Boston, MA.
Davies K; Harvard Medical School, Boston, MA.
Pikman Y; Department of Pathology, Boston Children's Hospital, Boston, MA; and.

Blood Adv ; 6(9): 2893-2896, 2022 05 10.

Article em En | MEDLINE | ID: mdl-35090166

Assuntos

Síndrome de Down; Reação Leucemoide; Sequenciamento de Nucleotídeos em Larga Escala; Humanos; Recém-Nascido

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Síndrome de Down / Reação Leucemoide Tipo de estudo: Diagnostic_studies Limite: Humans / Newborn Idioma: En Revista: Blood Adv Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google